Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CADL

Candel Therapeutics (CADL)

Candel Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CADL
DateTimeSourceHeadlineSymbolCompany
14/03/202507:45Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CADLCandel Therapeutics Inc
14/03/202507:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CADLCandel Therapeutics Inc
14/03/202507:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
14/03/202507:15GlobeNewswire Inc.Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsNASDAQ:CADLCandel Therapeutics Inc
26/02/202500:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
26/02/202500:00GlobeNewswire Inc.Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic CancerNASDAQ:CADLCandel Therapeutics Inc
15/02/202509:32Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CADLCandel Therapeutics Inc
15/02/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/02/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/02/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
15/02/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
18/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
18/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
18/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
18/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
16/01/202500:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
16/01/202500:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
16/01/202500:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
16/01/202500:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
14/01/202500:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CADLCandel Therapeutics Inc
14/01/202500:00GlobeNewswire Inc.Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025NASDAQ:CADLCandel Therapeutics Inc
11/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
11/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
11/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
11/01/202508:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CADLCandel Therapeutics Inc
09/01/202500:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
09/01/202500:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
09/01/202500:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
09/01/202500:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CADLCandel Therapeutics Inc
17/12/202408:01GlobeNewswire Inc.Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesNASDAQ:CADLCandel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CADL